Alembic Pharma sells its Baddi unit to Scott Edil Pharmacia

Engaged in developing formulations and active pharmaceutical ingredients (API), Alembic Pharma has sold its formulations’ manufacturing facility at Baddi to Scott Edil Pharmacia (SEPL). 
 
SEPL does not belong to the promoter or promoter group or group companies and is not related party of the company. Alembic Pharma continues to meet its domestic formulation demand from its Sikkim unit and international formulation demand from its Panelav unit.
 
The share price of Alembic Pharma was trading at Rs 515.70, up by 1.99% in the pre-market session on Thursday at 0952 hours. The stock has witnessed turnover of Rs 7 lakh and turnover quantity of 1,358 on the BSE.